Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-30

Clinical Trial Update: IV Iron Treatment of Restless Legs Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravenous iron for restless legs syndrome was withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Restless Legs Syndrome | Phase 2 | Status: WITHDRAWN